Freedom Meditech

Freedom Meditech is a private, growth-stage medical device company focused on the development and commercialization of first-to-market, non-invasive, ophthalmic medical devices that detect autofluorescence of the lens (ClearPath DS-120) and help monitor diabetes (our non-invasive glucose monitor). In the U.S. there are about 25.8 million people with diabetes and another estimated 79 million with pre-diabetes. The World Health Organization estimates 220 million people live with diabetes worldwide today and will more than double by 2030. The company operates out of two facilities. Corporate activities and product development are led from San Diego, California. Research and clinical studies for our diabetes monitoring device are performed throughout the state of Ohio.
Type
Private
HQ
San Diego, US
Founded
2006
Employees
13 (est)

Key People at Freedom Meditech

Mark R. Miehle

Mark R. Miehle

Senior VP of Sales and Distribution
Craig H. Misrach

Craig H. Misrach

Founder, Chairman, and CEO
Paul William

Paul William

VP of Research and Development
Keith D. Ignotz

Keith D. Ignotz

President & Chief Operating Officer
John Burd

John Burd

Chief Science Officer & Board of Directors

Freedom Meditech Locations

San Diego, US
San Diego, US
Cleveland, US

Freedom Meditech Metrics

Freedom Meditech Summary

Founding Date

2006

Total Funding

$19.8 M

Investors

Freedom Meditech Online Presence

Freedom Meditech News

Freedom Meditech Company Life